- Home
- Featured Publications
- Center Publications
- Activated CaMKII Binds to the mGlu Metabotropic Glutamate Receptor and Modulates Calcium Mobilization.
Activated CaMKII Binds to the mGlu Metabotropic Glutamate Receptor and Modulates Calcium Mobilization.
Citation | “Activated Camkii Binds To The Mglu Metabotropic Glutamate Receptor And Modulates Calcium Mobilization.”. Molecular Pharmacology, pp. 1352-1362. . |
Center | Vanderbilt University |
Author | Christian R Marks, Brian C Shonesy, Xiaohan Wang, Jason R Stephenson, Colleen M Niswender, Roger J Colbran |
Abstract |
Ca/calmodulin-dependent protein kinase II (CaMKII) and metabotropic glutamate receptor 5 (mGlu) are critical signaling molecules in synaptic plasticity and learning/memory. Here, we demonstrate that mGlu is present in CaMKII complexes isolated from mouse forebrain. Further in vitro characterization showed that the membrane-proximal region of the C-terminal domain (CTD) of mGlu directly interacts with purified Thr286-autophosphorylated (activated) CaMKII However, the binding of CaMKII to this CTD fragment is reduced by the addition of excess Ca/calmodulin or by additional CaMKII autophosphorylation at non-Thr286 sites. Furthermore, in vitro binding of CaMKII is dependent on a tribasic residue motif Lys-Arg-Arg (KRR) at residues 866-868 of the mGlu-CTD, and mutation of this motif decreases the coimmunoprecipitation of CaMKII with full-length mGlu expressed in heterologous cells by about 50%. The KRR motif is required for two novel functional effects of coexpressing constitutively active CaMKII with mGlu in heterologous cells. First, cell-surface biotinylation studies showed that CaMKII increases the surface expression of mGlu Second, using Ca fluorimetry and single-cell Ca imaging, we found that CaMKII reduces the initial peak of mGlu-mediated Ca mobilization by about 25% while doubling the relative duration of the Ca signal. These findings provide new insights into the physical and functional coupling of these key regulators of postsynaptic signaling. |
Year of Publication |
2018
|
Journal |
Molecular pharmacology
|
Volume |
94
|
Issue |
6
|
Number of Pages |
1352-1362
|
Date Published |
12/2018
|
ISSN Number |
1521-0111
|
DOI |
10.1124/mol.118.113142
|
Alternate Journal |
Mol. Pharmacol.
|
PMID |
30282777
|
PMCID |
PMC6207916
|
Download citation |